S&P 500
(0.12%) 5 303.27 points

Dow Jones
(0.34%) 40 004 points

Nasdaq
(-0.07%) 16 686 points

Oil
(-0.10%) $79.98

Gas
(1.37%) $2.66

Gold
(0.85%) $2 438.00

Silver
(4.05%) $32.53

Platinum
(0.94%) $1 100.20

USD/EUR
(-0.03%) $0.920

USD/NOK
(-0.08%) $10.67

USD/GBP
(0.04%) $0.787

USD/RUB
(0.09%) $91.05

Realtime updates for JCR Pharmaceuticals Co., [4552.T]

Exchange: JPX Sector: Healthcare Industry: Drug Manufacturers—General

Last Updated19 May 2024 @ 22:35

25% discount on Stockinvest.us - Use code: Podcast

3.38% ¥ 643.00

Live Chart Being Loaded With Signals

Commentary (19 May 2024 @ 22:35):

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan...

Stats
Today's Volume	581 300
Average Volume	762 512
Market Cap	80.25B
EPS	¥0 ( 2024-05-10 )
Next earnings date	( ¥0 ) 2024-07-24
Last Dividend	¥10.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	14.64
ATR14	¥0.758 (0.12%)

Volume Correlation

Long: -0.19 (neutral)

Short: 0.10 (neutral)

Signal:(37.217) Neutral

JCR Pharmaceuticals Co., Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

JCR Pharmaceuticals Co., Correlation - Currency/Commodity

0.76
( moderate )

0.66
( moderate )

0.16
( neutral )

0.68
( moderate )

-0.32
( neutral )

-0.67
( moderate negative )

JCR Pharmaceuticals Co., Financials

Annual	2023
Revenue:	¥42.87B
Gross Profit:	¥31.25B (72.90 %)
EPS:	¥44.14

FY	2023
Revenue:	¥42.87B
Gross Profit:	¥31.25B (72.90 %)
EPS:	¥44.14

FY	2022
Revenue:	¥34.34B
Gross Profit:	¥25.46B (74.13 %)
EPS:	¥30.34

FY	2022
Revenue:	¥51.08B
Gross Profit:	¥40.62B (79.52 %)
EPS:	¥117.26

Financial Reports:

No articles found.

JCR Pharmaceuticals Co., Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥10.00 (N/A)	¥0 (N/A)	¥10.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

JCR Pharmaceuticals Co., Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.67 - good (96.71%) | Divividend Growth Potential Score: 5.85 - Stable (17.02%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥1.250	2007-09-25
Last Dividend	¥10.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	30	--
Total Paid Out	¥100.88	--
Avg. Dividend % Per Year	0.00%	--
Score	3.63	--
Div. Sustainability Score	9.67
Div.Growth Potential Score	5.85
Div. Directional Score	7.76	--

Next Divdend (Est)
(2024-09-30)

¥0 Estimate 0.00 %

Dividend Stability

0.09 Very Bad

Dividend Score

3.63

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
8014.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0	0.00%
7261.T	Ex Dividend Knight	2023-09-28	Annually	0	0.00%
6493.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0	0.00%
5707.T	Ex Dividend Junior	2024-03-28	Annually	0	0.00%
4527.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0	0.00%
3683.T	Ex Dividend Knight	2023-12-28	Annually	0	0.00%
2982.T	Ex Dividend Junior	2023-12-28	Annually	0	0.00%
1847.T	Ex Dividend Junior	2023-09-28	Annually	0	0.00%
9842.T	Ex Dividend Junior	2024-02-28	Semi-Annually	0	0.00%
8905.T	Ex Dividend Knight	2024-02-28	Semi-Annually	0	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.128	1.500	7.43	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0539	1.200	8.20	9.84	[0 - 0.3]
returnOnEquityTTM	0.0995	1.500	-0.00538	-0.00807	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.911	0.800	5.45	4.36	[1 - 3]
quickRatioTTM	1.118	0.800	8.13	6.50	[0.8 - 2.5]
cashRatioTTM	0.622	1.500	7.65	10.00	[0.2 - 2]
debtRatioTTM	0.228	-1.500	6.20	-9.30	[0 - 0.6]
interestCoverageTTM	87.58	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	36.12	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	36.12	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.415	-1.500	8.34	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.729	1.000	1.184	1.184	[0.2 - 0.8]
operatingProfitMarginTTM	0.176	1.000	8.49	8.49	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.195	1.000	-0.0281	-0.0281	[0.2 - 2]
assetTurnoverTTM	0.419	0.800	-0.538	-0.430	[0.5 - 2]
Total Score				9.67

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	14.20	1.000	8.67	0	[1 - 100]
returnOnEquityTTM	0.0995	2.50	-0.00346	-0.00807	[0.1 - 1.5]
freeCashFlowPerShareTTM	36.12	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	3.22	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	36.12	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.682	1.500	8.79	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.106	1.000	9.85	0	[0.1 - 0.5]
Total Score				5.85

JCR Pharmaceuticals Co., Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

JCR Pharmaceuticals Co.,

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.